Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
An immobilization stress (IS) of 1 h applied at the beginning of the dark phase is followed by a sleep rebound. During the restraint, serotonin released by the dorsal raphe nucleus within the arcuate area stimulates the availability of
corticotropin
-like intermediate lobe peptide (CLIP or ACTH18-39). Three hours after the restraint, CLIP, through its hypnogenic properties, contributes to the sleep rebound that follows the IS. Here, we immunohistochemically evaluated protein expression of the immediate early gene, c-Fos and phosphorylated extracellular signal-regulated kinase (p-ERK) in hypothalamic (preoptic area [POA], paraventricular nucleus [PVN], arcuate nucleus [
ARC
]) and brain stem (dorsal raphe [DR], locus coeruleus [LC]) nuclei involved in the acute response to stress and the subsequent stress-related sleep rebound (recovery period). Immediately after the 1-h restraint, c-Fos and p-ERK expression increased in all structures studied, particularly in PVN and LC. Three hours later, the number of p-ERK- and c-Fos-positive neurons was reduced in PVN and LC (p < 0.001) as well as in DR (p < 0.01) compared to control animals. In contrast, both c-Fos and p-ERK expression in POA neurons (p < 0.01) and c-Fos expression in
ARC
neurons (p < 0.001) were increased 3 h after the IS. The marked activation observed in PVN and LC nucleus immediately after the IS confirms that these structures are clearly reactive to stress. However, the high activity observed in POA and
ARC
neurons during the recovery period, not described to date, highlights the particular part played by these structures in the stress-related sleep rebound. An unbalance in the above processes may contribute to pathological outcomes, such as anxiety and depression.
...
PMID:Expression patterns of c-Fos early gene and phosphorylated ERK in the rat brain following 1-h immobilization stress: concomitant changes induced in association with stress-related sleep rebound. 2466 3
To meet the challenge to human health posed by obesity, a better understanding of the regulation of feeding is essential. Medications targeting 5-hydroxytryptamine (5-HT; serotonin) 2C receptors (htr2c; 5-HT
2C
R) improve obesity. Here we probed the functional significance of 5-HT
2C
Rs specifically within the brainstem nucleus of the solitary tract (5-HT
2C
R
NTS
) in feeding behavior. Selective activation of 5-HT
2C
R
NTS
decreased feeding and was sufficient to mediate acute food intake reductions elicited by the 5-HT
2C
R agonist obesity medication lorcaserin. Similar to pro-
opiomelanocortin
neurons expressed within the hypothalamic arcuate nucleus (POMC
ARC
), a subset of POMC
NTS
neurons co-expressed 5-HT
2C
Rs and were activated by 5-HT
2C
R agonists. Knockdown of POMC
NTS
prevented the acute appetite-suppressive effect of lorcaserin, whereas POMC
ARC
knockdown prevented the full anorectic effect. These data identify 5-HT
2C
R
NTS
as a sufficient subpopulation of 5-HT
2C
Rs in reducing food intake when activated and reveal that 5-HT
2C
R agonist obesity medications require POMC within the NTS and
ARC
to reduce food intake.
...
PMID:Nucleus of the Solitary Tract Serotonin 5-HT
2C
Receptors Modulate Food Intake. 3028 43
<< Previous
1
2
3